Lifecare AS (LIFE) - Total Assets
Based on the latest financial reports, Lifecare AS (LIFE) holds total assets worth Nkr85.47 Million NOK (≈ $8.99 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore working capital position of Lifecare AS to assess how much short-term liquidity the company maintains relative to its equity base.
Lifecare AS - Total Assets Trend (2015–2024)
This chart illustrates how Lifecare AS's total assets have evolved over time, based on quarterly financial data.
Lifecare AS - Asset Composition Analysis
Current Asset Composition (December 2024)
Lifecare AS's total assets of Nkr85.47 Million consist of 66.5% current assets and 33.6% non-current assets. Also see Lifecare AS market capitalisation for the company's overall valuation and market capitalisation.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 54.7% |
| Accounts Receivable | Nkr5.88 Million | 5.2% |
| Inventory | Nkr0.00 | 0.0% |
| Property, Plant & Equipment | Nkr0.00 | 0.0% |
| Intangible Assets | Nkr5.37 Million | 4.8% |
| Goodwill | Nkr7.23 Million | 6.4% |
Asset Composition Trend (2015–2024)
This chart illustrates how Lifecare AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Lifecare AS (LIFE) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lifecare AS's current assets represent 66.5% of total assets in 2024, a decrease from 94.9% in 2015.
- Cash Position: Cash and equivalents constituted 54.7% of total assets in 2024, up from 17.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 5.0% in 2015.
- Asset Diversification: The largest asset category is goodwill at 6.4% of total assets.
Lifecare AS Competitors by Total Assets
Key competitors of Lifecare AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SIEMENS HEALTH ADR/050
F:SHL1
|
Germany | €44.27 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
Somnomed Ltd
AU:SOM
|
Australia | AU$79.90 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
|
Promimic AB
ST:PRO
|
Sweden | Skr75.71 Million |
Lifecare AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.22 | 2.50 | 11.21 |
| Quick Ratio | 0.22 | 2.50 | 11.21 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr-40.09 Million | Nkr56.20 Million | Nkr13.11 Million |
Lifecare AS - Advanced Valuation Insights
This section examines the relationship between Lifecare AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.21 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | 30.3% |
| Total Assets | Nkr112.59 Million |
| Market Capitalization | $6.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Lifecare AS's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Lifecare AS's assets grew by 30.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Lifecare AS (2015–2024)
The table below shows the annual total assets of Lifecare AS from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr112.59 Million ≈ $11.85 Million |
+30.33% |
| 2023-12-31 | Nkr86.39 Million ≈ $9.09 Million |
+23.46% |
| 2022-12-31 | Nkr69.97 Million ≈ $7.36 Million |
+117.16% |
| 2021-12-31 | Nkr32.22 Million ≈ $3.39 Million |
+120.56% |
| 2020-12-31 | Nkr14.61 Million ≈ $1.54 Million |
-16.49% |
| 2019-12-31 | Nkr17.49 Million ≈ $1.84 Million |
-25.29% |
| 2018-12-31 | Nkr23.42 Million ≈ $2.46 Million |
+1868.03% |
| 2017-12-31 | Nkr1.19 Million ≈ $125.22K |
-36.03% |
| 2016-12-31 | Nkr1.86 Million ≈ $195.73K |
-18.24% |
| 2015-12-31 | Nkr2.27 Million ≈ $239.39K |
-- |
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures … Read more